vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and High Tide Inc. (HITI). Click either name above to swap in a different company.
BALCHEM CORP is the larger business by last-quarter revenue ($263.6M vs $142.5M, roughly 1.9× High Tide Inc.). BALCHEM CORP runs the higher net margin — 14.9% vs -1.9%, a 16.8% gap on every dollar of revenue.
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
High Tide Inc. is a Canada-based consumer retail and lifestyle company focused on the global cannabis sector. It operates a large network of licensed cannabis dispensaries across North America, sells cannabis consumption accessories and branded cannabis products, and runs multiple leading e-commerce platforms catering to recreational and medical cannabis users.
BCPC vs HITI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $142.5M |
| Net Profit | $39.2M | $-2.7M |
| Gross Margin | 35.6% | — |
| Operating Margin | 19.8% | 0.0% |
| Net Margin | 14.9% | -1.9% |
| Revenue YoY | 9.8% | — |
| Net Profit YoY | 16.8% | — |
| EPS (diluted) | $1.21 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $142.5M | ||
| Q4 25 | $263.6M | — | ||
| Q3 25 | $267.6M | $131.7M | ||
| Q2 25 | $255.5M | $124.3M | ||
| Q1 25 | $250.5M | — | ||
| Q4 24 | $240.0M | $128.1M | ||
| Q3 24 | $239.9M | — | ||
| Q2 24 | $234.1M | — |
| Q1 26 | — | $-2.7M | ||
| Q4 25 | $39.2M | — | ||
| Q3 25 | $40.3M | $991.0K | ||
| Q2 25 | $38.3M | $166.0K | ||
| Q1 25 | $37.1M | — | ||
| Q4 24 | $33.6M | — | ||
| Q3 24 | $33.8M | — | ||
| Q2 24 | $32.1M | — |
| Q1 26 | — | — | ||
| Q4 25 | 35.6% | — | ||
| Q3 25 | 35.7% | 26.9% | ||
| Q2 25 | 36.4% | 28.4% | ||
| Q1 25 | 35.2% | — | ||
| Q4 24 | 36.0% | 28.1% | ||
| Q3 24 | 35.6% | — | ||
| Q2 24 | 35.5% | — |
| Q1 26 | — | 0.0% | ||
| Q4 25 | 19.8% | — | ||
| Q3 25 | 20.4% | 2.3% | ||
| Q2 25 | 20.1% | 1.6% | ||
| Q1 25 | 20.4% | — | ||
| Q4 24 | 19.8% | 2.2% | ||
| Q3 24 | 20.0% | — | ||
| Q2 24 | 19.6% | — |
| Q1 26 | — | -1.9% | ||
| Q4 25 | 14.9% | — | ||
| Q3 25 | 15.1% | 0.8% | ||
| Q2 25 | 15.0% | 0.1% | ||
| Q1 25 | 14.8% | — | ||
| Q4 24 | 14.0% | — | ||
| Q3 24 | 14.1% | — | ||
| Q2 24 | 13.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.21 | — | ||
| Q3 25 | $1.24 | — | ||
| Q2 25 | $1.17 | — | ||
| Q1 25 | $1.13 | — | ||
| Q4 24 | $1.03 | — | ||
| Q3 24 | $1.03 | — | ||
| Q2 24 | $0.98 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.3B | — |
| Total Assets | $1.7B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $74.6M | — | ||
| Q3 25 | $65.1M | — | ||
| Q2 25 | $65.4M | — | ||
| Q1 25 | $49.9M | — | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $73.7M | — | ||
| Q2 24 | $63.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.1B | — |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | — | ||
| Q3 25 | $1.7B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 1.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $67.3M | — | ||
| Q3 25 | $65.6M | — | ||
| Q2 25 | $47.3M | — | ||
| Q1 25 | $36.5M | — | ||
| Q4 24 | $52.3M | — | ||
| Q3 24 | $51.3M | — | ||
| Q2 24 | $45.0M | — |
| Q1 26 | — | — | ||
| Q4 25 | 1.72× | — | ||
| Q3 25 | 1.63× | — | ||
| Q2 25 | 1.23× | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 1.56× | — | ||
| Q3 24 | 1.52× | — | ||
| Q2 24 | 1.40× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
HITI
Segment breakdown not available.
